PHARMASGP HOLDING SE O.N.
PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
PSG
|
13/11/2024 08:01:47
|
Chg.
-0.200
|
Volume |
Bid21:26:14 |
Demandez à21:26:14 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
24.400EUR
|
-0.81%
|
0
Chiffrre d'affaires: 0.000 |
-Bid taille: - |
-Ask la taille: - |
292.62 Mio.EUR |
5.57% |
17.81 |
Description de l'entreprise
PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products. PharmaSGP’s products are sold exclusively through pharmacies. Its products are based on natural active pharmaceutical ingredients with documented efficacy and fewer known side effects than most chemical-based pharmaceuticals. The Company’s core brands cover chronic indications, including pain and other age-related ailments.
Conseil d'administration & Conseil de surveillance
| PDG |
| Natalie Weigand |
| Conseil d'administration |
| Michael Rudolf, Peter Gerckens |
| Conseil de surveillance |
| Dr. Clemens Fischer, Madlena Hohlefelder, Dr. Axel Rebien |
Données de l'entreprise
| Nom: |
PharmaSGP Holding SE |
| Adresse: |
Lochhamer Schlag 21,D-82166 Gräfelfing |
| Téléphone: |
+49-611-2058-5528 |
| Fax: |
+49-611-2058-5566 |
| Courriel: |
info@pharmasgp.com
|
| Internet: |
https://pharmasgp.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
- |
| IPO date: |
19/06/2020 |
Relations avec les investisseurs
| Nom: |
Claudius Krause |
| Téléphone IR: |
+49-611-2058-5535 |
| IR-Fax: |
- |
| E-mail IR: |
ir@pharmasgp.com
|
Calendrier de l'entreprise
|
CW 48 | 28/11/2024
Interim Report 3rd Quarter/9 Months
|
